Weekly Colgate-Palmolive Company (NYSE:CL) Ratings as of May 17, 2018

May 17, 2018 - By James Douglas

During Q4 2017 the big money sentiment decreased to 0.87. That’s change of 0.03, from 2017Q3’s 0.9. 56 investors sold all, 444 reduced holdings as Colgate-Palmolive Company ratio fall. 335 rose stakes while 98 funds took stakes. Funds hold 606.34 million shares thus 1.77% less from 2017Q3’s 617.24 million shares.
Mcdaniel Terry Commerce has 0.06% invested in Colgate-Palmolive Company (NYSE:CL) for 4,268 shs. Park Natl Oh invested in 69,316 shs or 0.29% of the stock. Hemenway Trust Ltd Liability Corporation owns 0.34% invested in Colgate-Palmolive Company (NYSE:CL) for 23,550 shs. Pennsylvania owns 97,922 shs or 0.33% of their US capital. First Interstate Fincl Bank reported 830 shs or 0.01% of all its holdings. Triangle Secs Wealth holds 15,753 shs. North Amer Corporation reported 229,790 shs or 2.64% of all its holdings. Cibc World Markets Incorporated reported 66,454 shs. Moreover, Asset Management has 0.19% invested in Colgate-Palmolive Company (NYSE:CL) for 76,566 shs. Bb&T Secs Lc holds 50,704 shs or 0.05% of its capital. Davis R M owns 192,940 shs or 0.57% of their US capital. Schnieders Mngmt Llc has invested 0.71% in Colgate-Palmolive Company (NYSE:CL). Paragon Cap Mgmt Limited holds 0.72% or 24,196 shs in its capital. Mai Cap Mgmt owns 17,848 shs. Mairs & has 0.01% invested in Colgate-Palmolive Company (NYSE:CL) for 9,194 shs.

Colgate-Palmolive Company registered $40.52 million net activity with 0 insider purchases and 24 sales since December 13, 2017. HANCOCK ELLEN M had sold 4,676 shs worth $346,581 on Wednesday, January 31. On Tuesday, February 20 Wallace Noel R. sold $321,701 worth of Colgate-Palmolive Company (NYSE:CL). Marsili Daniel B sold $1.40 million worth of Colgate-Palmolive Company (NYSE:CL) or 19,500 shs on Monday, April 16. $110,310 worth of Colgate-Palmolive Company (NYSE:CL) was sold by Verduin Patricia. $106,939 worth of Colgate-Palmolive Company (NYSE:CL) was sold by HUSTON JOHN J. 7,000 Colgate-Palmolive Company (NYSE:CL) shs with value of $489,696 were sold by CAHILL JOHN T.

Colgate-Palmolive Company (NYSE:CL) Ratings Coverage

Total analysts of 10 have positions in Colgate-Palmolive (NYSE:CL) as follows: 1 rated it a “Buy”, 1 with “Sell” and 8 with “Hold”. The positive are 10%. Since November 22, 2017 according to StockzIntelligence Inc Colgate-Palmolive has 12 analyst reports. On Friday, April 20 the firm has “Overweight” rating by Morgan Stanley given. On Tuesday, May 1 the rating was maintained by Citigroup with “Neutral”. On Wednesday, November 22 KeyBanc Capital Markets maintained the shares of CL in report with “Hold” rating. In Thursday, January 4 report Jefferies maintained the stock with “Hold” rating. On Monday, April 30 the rating was downgraded by Morgan Stanley to “Hold”. On Tuesday, January 30 the firm earned “Neutral” rating by Citigroup. In Tuesday, April 17 report Stifel Nicolaus maintained it with “Hold” rating and $7500 target. In Wednesday, November 29 report Societe Generale downgraded the stock to “Sell” rating. On Tuesday, December 19 the rating was upgraded by Macquarie Research to “Outperform”. Listed here are Colgate-Palmolive Company (NYSE:CL) PTs and latest ratings.

01/05/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $80 New Target: $73 Maintain
30/04/2018 Broker: Morgan Stanley Rating: Hold Downgrade
20/04/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $82 New Target: $80 Maintain
17/04/2018 Broker: Stifel Nicolaus Rating: Hold New Target: $75.0000 Maintain
15/03/2018 Broker: Barclays Capital Rating: Hold New Target: $75.0
30/01/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $75 New Target: $80 Maintain
26/01/2018 Broker: Wells Fargo Rating: Hold New Target: $73.0
04/01/2018 Broker: Jefferies Rating: Hold New Target: $79.0 Maintain
19/12/2017 Broker: Macquarie Research Old Rating: Neutral New Rating: Outperform Old Target: $76 Upgrade
14/12/2017 Broker: Deutsche Bank Rating: Hold Initiates Coverage On

CL hit $61.92 during the last trading session after $0.17 change.Currently Colgate-Palmolive Company is downtrending after 5.65% change in last May 17, 2017. CL has also 2.24M shares volume. The stock underperformed the S&P 500 by 17.20%.

Colgate-Palmolive Company, together with its subsidiaries, makes and sells consumer products worldwide.The company has $54.01 billion market cap. It operates through two divisions, Oral, Personal and Home Care; and Pet Nutrition.26.25 is the P/E ratio. The firm offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, and other related products.

More recent Colgate-Palmolive Company (NYSE:CL) news were released by Benzinga.com, Seekingalpha.com and Seekingalpha.com. The first one has “Morgan Stanley Shifts To Neutral On Colgate-Palmolive, Cites Emerging Markets Weakness” as a title and was released on April 30, 2018. The next is “Retirement Strategy: I Am Done Being Wrong About This Market” on May 16, 2018. And last was released on May 14, 2018, called “Colgate-Palmolive: A Consumer Defensive Heavyweight”.

Colgate-Palmolive Company (NYSE:CL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.